Director of the Cold Spring Harbor Laboratory (CSHL) Cancer Center and Roy J. Zuckerberg Professor of Cancer Research David Tuveson and Assistant Professor Tobias Janowitz wrote an editorial in the latest edition of Cancer Discovery. The piece, entitled “The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research”, discusses the active participation of cancer researchers in COVID-19 research and how it can help future scientific endeavors.
“COVID-19 has greatly threatened the care of patients with other diseases, and this has been further motivation to researchers and doctors from a diverse range of disciplines to apply their skills to COVID-19. This is especially true for cancer researchers,” they explain. One such researcher is CSHL Assistant Professor Mikala Egeblad, whose research into neutrophil extracellular traps (NETs) has implications for both cancer and COVID-19 treatment. Both Tuveson and Janowitz also developed an outpatient symptom tracking method based on a model used in cancer research.
The authors add that cancer researchers are used to working with illnesses that affect multiple parts of the body, as COVID-19 does, and are knowledgeable on methods that bolster or lessen the immune system. They also advocate that this shift to studying the SARS-CoV-2 virus could help build interdisciplinary bridges:
“Our time engaging with non-cancer experts in the battle against the COVID-19 pandemic may usher in a new type of scientific collectivism where we more openly share ideas and approaches to rapidly develop effective therapies and diagnostics for both COVID-19 and cancer patients.”
Read the entire editorial on the Cancer Discovery website. Both Tuveson and Janowitz discussed this topic and more, at the virtual American Association for Cancer Research meeting, entitled “COVID-19 and Cancer”, on July 20–22, 2020.
"Mkurugenzi wa Maabara ya Cold Spring Harbor (CSHL) na Profesa wa Utafiti wa Saratani Roy J. Zuckerberg, David Tuvison na Profesa Msaidizi Tobias Janowitz, waliandika katika toleo la hivi karibuni la ""Ugunduzi wa Saratani.""" "Kichapo hicho, kilichoitwa ""The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research,"" kinajadili ushiriki wa watafiti wa kansa katika utafiti wa COVID-19 na jinsi inavyoweza kusaidia juhudi za kisayansi za baadaye." "COVID-19 imehatarisha sana utunzaji wa wagonjwa wenye magonjwa mengine, na hii imekuwa motisha zaidi kwa watafiti na madaktari kutoka kwa safu mbalimbali za taaluma kutumia ujuzi wao kwa COVID-19.""" Hii ni kweli hasa kwa watafiti wa kansa, <unk> wao kueleza. Mtafiti mmoja wa CSHL, Profesa Msaidizi Mikala Egeblad, ambaye utafiti wake juu ya mitego ya nje ya seli ya neutrophil (NET) una athari kwa matibabu ya saratani na COVID-19. Tuveson na Janowitz pia waliendeleza mbinu ya kufuatilia dalili za wagonjwa wa nje kulingana na mfano unaotumiwa katika utafiti wa kansa. "Wanafunzi wa utafiti wa saratani wamezoea kufanya kazi na magonjwa ambayo huathiri sehemu nyingi za mwili, kama vile COVID-19 inafanya, na wana ujuzi juu ya mbinu ambazo zinaimarisha au kupunguza mfumo wa kinga.""" "Wanaunga mkono pia kwamba mabadiliko haya ya kusoma virusi vya SARS-CoV-2 yanaweza kusaidia kujenga madaraja ya interdisciplinary: ""Wakati wetu wa kushirikiana na wataalamu wasio wa saratani katika vita dhidi ya janga la COVID-19 unaweza kuanzisha aina mpya ya ushirika wa kisayansi ambapo tunashiriki wazi zaidi mawazo na mbinu za kuendeleza haraka matibabu na utambuzi wa wagonjwa wa COVID-19 na saratani. """ Tuvison na Janowitz walijadili mada hii na zaidi, katika mkutano wa mtandao wa Chama cha Amerika cha Utafiti wa Saratani, wenye jina la <unk>COVID-19 na Saratani<unk>, Julai 20-22, 2020.